Introduction：Basic information about CAS 1103522-45-7|ACT-132577, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | ACT-132577 |
|---|
| CAS Number | 1103522-45-7 | Molecular Weight | 546.19300 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C16H14Br2N6O4S | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | N-Despropyl-macitentan |
|---|
| Synonym | More Synonyms |
|---|
ACT-132577 BiologicalActivity
| Description | ACT-132577 is the major and pharmacologically active metabolite of macitentan, which is dual ETA/ETB antagonist designed for tissue targeting. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Endothelin ReceptorResearch Areas >>Cardiovascular Disease |
|---|
| In Vitro | ACT-132577 achieves full inhibition of intracellular calcium increase induced by ET-1 on nonrecombinant cells (primary human pulmonary smooth muscle cells and rat aortic smooth muscle cell line A10 and mouse fibroblast cell line 3T3)[1]. |
|---|
| In Vivo | ACT-132577 has a volume of distribution greater than the plasma volume and a longer half-life than its parent compound in the rat[1]. In rat plasma, the mean recovery of ACT-132577 ranges from 82.6% to 90.6%, matrix effect of ACT-132577 in rat plasma ranges from 101.4% to 115.2%[2]. |
|---|
| Kinase Assay | The competition binding assay is performed in 200 μL of 50 mM Tris/HCl buffer, pH 7.4, including 25 mM MnCl2, 1 mM EDTA, 0.5% (w/v) bovine serum albumin (fraction V), and 50 μg/mL 4-(2-aminoethyl)benzenesulfonyl fluoride in polypropylene microtiter plates. Membranes containing 0.5 μg of protein (ETA) or 0.2 μg of protein (ETB) are incubated for 2 h at room temperature with 16 pM 125I-ET-1 (8000 cpm) and increasing concentrations of unlabeled test compounds. Maximal and minimal binding is determined in samples without and with 100 nM unlabeled ET-1, respectively. After 2 h of incubation, the membranes are filtered onto filter plates containing GF/C filters. To each well, 50 μL of scintillation cocktail is added, and the filter plates counted in a microplate counter. Test compounds are dissolved, diluted, and added to the assay in dimethyl sulfoxide. The final concentration of dimethyl sulfoxide in the assay is 2.5%, which is found not to interfere with the binding. The IC50 value is calculated as the concentration of antagonist inhibiting 50% of the specific binding of ET-1. |
|---|
| References | [1]. Iglarz M, et al. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist. J Pharmacol Exp Ther. 2008 Dec;327(3):736-45. [2]. Zhang J, et al. Pharmacokinetic study of ACT-132577 in rat plasma by ultra performance liquid chromatography-tandem mass spectrometry. Int J Clin Exp Med. 2015 Oct 15;8(10):18420-6 |
|---|
Chemical & Physical Properties
| Molecular Formula | C16H14Br2N6O4S |
|---|
| Molecular Weight | 546.19300 |
|---|
| Exact Mass | 543.91600 |
|---|
| PSA | 150.59000 |
|---|
| LogP | 4.38590 |
|---|
| InChIKey | DKULOVKANLVDEA-UHFFFAOYSA-N |
|---|
| SMILES | NS(=O)(=O)Nc1ncnc(OCCOc2ncc(Br)cn2)c1-c1ccc(Br)cc1 |
|---|
Synonyms
